1. Home
  2. VTSI vs RLYB Comparison

VTSI vs RLYB Comparison

Compare VTSI & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.76

Market Cap

51.1M

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$8.24

Market Cap

44.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
RLYB
Founded
1993
2018
Country
United States
United States
Employees
N/A
14
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
44.6M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
VTSI
RLYB
Price
$3.76
$8.24
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$5.00
N/A
AVG Volume (30 Days)
50.1K
103.2K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$185,971.00
$858,000.00
Revenue This Year
$28.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$189.00
N/A
Revenue Growth
N/A
43.00
52 Week Low
$3.55
$0.22
52 Week High
$7.47
$11.49

Technical Indicators

Market Signals
Indicator
VTSI
RLYB
Relative Strength Index (RSI) 37.06 52.93
Support Level N/A $0.50
Resistance Level $4.68 $11.49
Average True Range (ATR) 0.25 0.65
MACD -0.07 -0.33
Stochastic Oscillator 18.62 25.92

Price Performance

Historical Comparison
VTSI
RLYB

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: